1Departamento de Fisioterapia en Cuidados Intensivos, SES Hospital Universitario de Caldas, Manizales, Colombia
2Grupo de Investigación GIHORO, Hospital Regional de la Orinoquia, Yopal, Colombia
3Department of Intensive Care, University Hospital of Heraklion, University of Crete School of Medicine, Heraklion, Crete, Greece
4Unidad de Cuidado Intensivo Clínica Reina Sofía, Clínica Colsanitas, Grupo de Investigación en Nutrición Clínica y Rehabilitación, Keralty, Bogotá, Colombia
5Critical Care Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain
6Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain
© 2026 The Korean Society of Critical Care Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
Lluís Blanch is an editorial board member of the journal but was not involved in the peer reviewer selection, evaluation, or decision process of this article.
Lluís Blanch is the inventor of a U.S. patent owned by Consorci Corporació Sanitària Parc Taulí: “Method and system for managed related patient parameters provided by a monitoring device,” US Patent No. 12/538,940. Lluís Blanch owns stock options of BetterCare S.L., a research and development spin-off of Consorci Corporació Sanitària Parc Taulí. No other potential conflicts of interest relevant to this article were reported.
FUNDING
None.
ACKNOWLEDGMENTS
None.
AUTHOR CONTRIBUTIONS
Conceptualization: AMEP, KV, HMPG, LB. Methodology: AMEP, KV, HMPG. Visualization: AMEP, KV, HMPG, LB. Writing - original draft: AMEP, KV. Writing - review & editing: AMEP, KV, HMPG, LB. All authors read and agreed to the published version of the manuscript.
| Study | Year | Type of study | Justification | |
|---|---|---|---|---|
| Explanation | Strategy | |||
| Ramírez et al. [8] | 2021 | Cross-sectional observational | × | |
| Enríquez Popayán et al. [9] | 2025 | Cross-sectional observational | × | |
| Ghamloush et al. [12] | 2011 | Narrative review | × | |
| de Wit et al. [13] | 2009 | Prospective observational | × | |
| Alexopoulou et al. [14] | 2013 | Crossover clinical trial | × | |
| Luo et al. [15] | 2020 | Prospective observational | × | |
| Saga et al. [16] | 2025 | Case report | × | × |
| Imanaka et al. [17] | 2000 | Observational experimental | × | |
| Saavedra et al. [18] | 2022 | Narrative review | × | |
| Mellott et al. [19] | 2009 | Narrative review | × | |
| López-Aguilar et al. [20] | 2013 | Narrative review | × | |
| Spinelli et al. [21] | 2020 | Narrative review | × | |
| Costa et al. [22] | 2025 | Narrative review | × | |
| Sontakke et al. [23] | 2023 | Systematic review | × | |
| Ramírez et al. [24] | 2024 | Prospective quasi-experimental | × | |
| Blanch et al. [25] | 2012 | Pilot observational | × | |
| Bakkes et al. [26] | 2023 | Algorithm validation | × | |
| Longhini et al. [27] | 2023 | Narrative review | × | |
| Wisse et al. [28] | 2024 | Qualitative observational | × | |
| Rae et al. [29] | 2021 | Systematic review | × | |
| Twigg et al. [30] | 2013 | Retrospective observational | × | |
| Thille et al. [31] | 2006 | Prospective observational | × | |
| Yujen et al. [32] | 2022 | Descriptive observational | × | |
| Holanda et al. [33] | 2018 | Narrative review | × | |
| Bulleri et al. [34] | 2018 | Narrative review | × | |
| Tanchuco et al. [35] | 2025 | Modeling/simulation | × | |
| Bloos et al. [36] | 2009 | Prospective cohort | × | |
| Colombo et al. [37] | 2011 | Prospective observational | × | |
| Lynch-Smith et al. [38] | 2016 | Quasi-experimental | × | |
| Nilsestuen et al. [39] | 2005 | Narrative review | × | |
| de Haro et al. [40] | 2019 | Narrative review | × | |
| Reader et al. [41] | 2007 | Qualitative observational | × | |
| Leonard et al. [42] | 2004 | Narrative review | × | |
| Challenge | Explanation | Strategy |
|---|---|---|
| Delirium/agitation | Delirium and agitation increase respiratory drive, whereas their pharmacological management may excessively suppress it; moreover, prolonged sedation is associated with a higher risk of delirium [12,13]. | · Avoid prolonged sedation |
| · Pharmacological delirium prevention | ||
| · Non-pharmacological delirium prevention | ||
| · Assisted ventilation modes | ||
| · High-risk patient monitoring | ||
| · Recognize high respiratory drive (not under-assistance) [14] | ||
| Acute brain injury | Patients with acute brain injury often have impaired respiratory control, high respiratory drive, and irregular breathing patterns that promote asynchronies [15]. | · Identify high-risk patients |
| · Address pathophysiology | ||
| · Frequent monitoring | ||
| · Control high respiratory drive (if indicated) | ||
| · Individualized ventilator settings | ||
| · Dynamic reassessment and adjustment [16] | ||
| Hemodynamic instability, small time constant of the respiratory system | Patients with low respiratory drive and short time constants are prone to auto-triggering [17], as cardiac oscillations may trigger the ventilator, allowing assisted ventilation without patient inspiratory effort. | · Identify at-risk patients |
| · Monitor for auto-triggering frequently | ||
| · Avoid excessive sedation and address low respiratory drive | ||
| · Adjust trigger sensitivity cautiously | ||
| · Differentiate cardiac oscillations from true patient efforts | ||
| · Determine patient-triggered versus ventilator-triggered breaths [18] | ||
| Altered respiratory drive due to metabolic acidosis or alkalosis | Metabolic acidosis increases respiratory drive through central chemoreceptor stimulation, whereas alkalosis suppresses it by inhibiting respiratory centers, leading to distinct PVA patterns and highlighting the role of brain–lung interactions in MV [19,21]. | · Identify at-risk patients |
| · Manage underlying metabolic disorders | ||
| · Adjust ventilator parameters according to clinical needs | ||
| · Prioritize lung-protective ventilation [16] | ||
| Dysfunction of the artificial airway | Secretions or water in artificial airways can cause multiple asynchronies, including auto-triggering and those related to increased airway resistance [16,22]. | · Clear endotracheal and tracheostomy tubes |
| · Remove airway secretions | ||
| · Ensure unobstructed airflow delivery [23] |
| Challenge | Explanation | Strategy |
|---|---|---|
| Inadequate staff training | Limited training in MV hinders effective PVA prevention and management, as poor waveform interpretation skills increase the risk of undetected or uncorrected asynchronies [8]. | · Develop targeted educational strategies |
| · Implement continuous PVA training for ventilatory support personnel [24] | ||
| Lack of frequent monitoring of ventilator waveforms | In daily clinical practice, it is nearly impossible for healthcare professionals to continuously monitor ventilator waveforms 24 hours a day [9]. | · Implement specialized software for asynchrony detection [25,26] |
| Lack of advanced monitoring | Advanced monitoring, such as esophageal and gastric pressure measurement, enables timely detection of asynchronies in complex cases and may reduce adverse clinical outcomes [27]. | · Deploy advanced monitoring technologies |
| · Use ventilators with esophageal pressure monitoring | ||
| · Conduct cost–benefit and economic impact analyses | ||
| ·Train staff in equipment use [18,28] | ||
| Limited support staff | A higher number of healthcare professionals would allow more frequent and detailed monitoring of ventilator waveforms, potentially reducing adverse clinical outcomes [29]. | · Evaluate additional ICU staffing needs |
| · Perform financial modeling | ||
| · Assess the economic benefits of increased staffing levels [30] | ||
| Discomfort associated with specific errors in the inappropriate setting of ventilatory parameters | Inadequate ventilator settings can induce the occurrence of asynchronies [31]. | · Regularly reassess patients |
| · Monitor ventilator waveforms | ||
| · Adjust ventilator parameters according to patient condition and clinical goals [32] | ||
| Inadequate programming of ventilatory alarms | Suboptimal alarm configuration (inappropriate thresholds, excessive alarm load, or poor alarm response protocols) may delay the recognition of clinically relevant events, contributing to missed asynchrony detection and delayed corrective interventions [33]. | · Regularly reassess and individualize alarm settings based on clinical goals and ventilator configuration [32] |
| Lack of ventilators with graphical monitoring capabilities | Although most mechanical ventilators provide waveform monitoring, its absence in some institutions hinders the detection of PVA [34]. | · Implement new ventilators |
| · Conduct financial cost analyses | ||
| · Assess economic benefits | ||
| · Train staff in equipment use [24,35,36] |
| Challenge | Explanation | Strategy |
|---|---|---|
| Underestimation of the clinical relevance and the adverse events associated with its presence | A low proportion of professionals recognize PVA in real time, indicating underestimation of both the presence and clinical impact of asynchronies [37]. | · Provide interprofessional education |
| · Train staff on the clinical impact of PVA [38] | ||
| Use of sedation to manage ventilator asynchronies | Sedation is sometimes inappropriately used to manage asynchronies [13]. | · Monitor ventilator waveforms |
| · Identify PVA | ||
| · Adjust ventilator settings according to patient condition | ||
| · Regularly reassess the patient | ||
| · Consider sedation only after confirming asynchrony and exhausting non-sedation alternatives [39,40] | ||
| Lack of communication among healthcare professionals | Lack of assertive communication among healthcare professionals can lead to misaligned goals and inconsistent treatment plans [41]. | · Implement structured interdisciplinary meetings |
| · Standardize communication protocols | ||
| · Promote coordination and alignment of therapeutic goals [42] |
| Study | Year | Type of study | Justification | |
|---|---|---|---|---|
| Explanation | Strategy | |||
| Ramírez et al. [8] | 2021 | Cross-sectional observational | × | |
| Enríquez Popayán et al. [9] | 2025 | Cross-sectional observational | × | |
| Ghamloush et al. [12] | 2011 | Narrative review | × | |
| de Wit et al. [13] | 2009 | Prospective observational | × | |
| Alexopoulou et al. [14] | 2013 | Crossover clinical trial | × | |
| Luo et al. [15] | 2020 | Prospective observational | × | |
| Saga et al. [16] | 2025 | Case report | × | × |
| Imanaka et al. [17] | 2000 | Observational experimental | × | |
| Saavedra et al. [18] | 2022 | Narrative review | × | |
| Mellott et al. [19] | 2009 | Narrative review | × | |
| López-Aguilar et al. [20] | 2013 | Narrative review | × | |
| Spinelli et al. [21] | 2020 | Narrative review | × | |
| Costa et al. [22] | 2025 | Narrative review | × | |
| Sontakke et al. [23] | 2023 | Systematic review | × | |
| Ramírez et al. [24] | 2024 | Prospective quasi-experimental | × | |
| Blanch et al. [25] | 2012 | Pilot observational | × | |
| Bakkes et al. [26] | 2023 | Algorithm validation | × | |
| Longhini et al. [27] | 2023 | Narrative review | × | |
| Wisse et al. [28] | 2024 | Qualitative observational | × | |
| Rae et al. [29] | 2021 | Systematic review | × | |
| Twigg et al. [30] | 2013 | Retrospective observational | × | |
| Thille et al. [31] | 2006 | Prospective observational | × | |
| Yujen et al. [32] | 2022 | Descriptive observational | × | |
| Holanda et al. [33] | 2018 | Narrative review | × | |
| Bulleri et al. [34] | 2018 | Narrative review | × | |
| Tanchuco et al. [35] | 2025 | Modeling/simulation | × | |
| Bloos et al. [36] | 2009 | Prospective cohort | × | |
| Colombo et al. [37] | 2011 | Prospective observational | × | |
| Lynch-Smith et al. [38] | 2016 | Quasi-experimental | × | |
| Nilsestuen et al. [39] | 2005 | Narrative review | × | |
| de Haro et al. [40] | 2019 | Narrative review | × | |
| Reader et al. [41] | 2007 | Qualitative observational | × | |
| Leonard et al. [42] | 2004 | Narrative review | × | |
| Challenge | Explanation | Strategy |
|---|---|---|
| Delirium/agitation | Delirium and agitation increase respiratory drive, whereas their pharmacological management may excessively suppress it; moreover, prolonged sedation is associated with a higher risk of delirium [12,13]. | · Avoid prolonged sedation |
| · Pharmacological delirium prevention | ||
| · Non-pharmacological delirium prevention | ||
| · Assisted ventilation modes | ||
| · High-risk patient monitoring | ||
| · Recognize high respiratory drive (not under-assistance) [14] | ||
| Acute brain injury | Patients with acute brain injury often have impaired respiratory control, high respiratory drive, and irregular breathing patterns that promote asynchronies [15]. | · Identify high-risk patients |
| · Address pathophysiology | ||
| · Frequent monitoring | ||
| · Control high respiratory drive (if indicated) | ||
| · Individualized ventilator settings | ||
| · Dynamic reassessment and adjustment [16] | ||
| Hemodynamic instability, small time constant of the respiratory system | Patients with low respiratory drive and short time constants are prone to auto-triggering [17], as cardiac oscillations may trigger the ventilator, allowing assisted ventilation without patient inspiratory effort. | · Identify at-risk patients |
| · Monitor for auto-triggering frequently | ||
| · Avoid excessive sedation and address low respiratory drive | ||
| · Adjust trigger sensitivity cautiously | ||
| · Differentiate cardiac oscillations from true patient efforts | ||
| · Determine patient-triggered versus ventilator-triggered breaths [18] | ||
| Altered respiratory drive due to metabolic acidosis or alkalosis | Metabolic acidosis increases respiratory drive through central chemoreceptor stimulation, whereas alkalosis suppresses it by inhibiting respiratory centers, leading to distinct PVA patterns and highlighting the role of brain–lung interactions in MV [19,21]. | · Identify at-risk patients |
| · Manage underlying metabolic disorders | ||
| · Adjust ventilator parameters according to clinical needs | ||
| · Prioritize lung-protective ventilation [16] | ||
| Dysfunction of the artificial airway | Secretions or water in artificial airways can cause multiple asynchronies, including auto-triggering and those related to increased airway resistance [16,22]. | · Clear endotracheal and tracheostomy tubes |
| · Remove airway secretions | ||
| · Ensure unobstructed airflow delivery [23] |
| Challenge | Explanation | Strategy |
|---|---|---|
| Inadequate staff training | Limited training in MV hinders effective PVA prevention and management, as poor waveform interpretation skills increase the risk of undetected or uncorrected asynchronies [8]. | · Develop targeted educational strategies |
| · Implement continuous PVA training for ventilatory support personnel [24] | ||
| Lack of frequent monitoring of ventilator waveforms | In daily clinical practice, it is nearly impossible for healthcare professionals to continuously monitor ventilator waveforms 24 hours a day [9]. | · Implement specialized software for asynchrony detection [25,26] |
| Lack of advanced monitoring | Advanced monitoring, such as esophageal and gastric pressure measurement, enables timely detection of asynchronies in complex cases and may reduce adverse clinical outcomes [27]. | · Deploy advanced monitoring technologies |
| · Use ventilators with esophageal pressure monitoring | ||
| · Conduct cost–benefit and economic impact analyses | ||
| ·Train staff in equipment use [18,28] | ||
| Limited support staff | A higher number of healthcare professionals would allow more frequent and detailed monitoring of ventilator waveforms, potentially reducing adverse clinical outcomes [29]. | · Evaluate additional ICU staffing needs |
| · Perform financial modeling | ||
| · Assess the economic benefits of increased staffing levels [30] | ||
| Discomfort associated with specific errors in the inappropriate setting of ventilatory parameters | Inadequate ventilator settings can induce the occurrence of asynchronies [31]. | · Regularly reassess patients |
| · Monitor ventilator waveforms | ||
| · Adjust ventilator parameters according to patient condition and clinical goals [32] | ||
| Inadequate programming of ventilatory alarms | Suboptimal alarm configuration (inappropriate thresholds, excessive alarm load, or poor alarm response protocols) may delay the recognition of clinically relevant events, contributing to missed asynchrony detection and delayed corrective interventions [33]. | · Regularly reassess and individualize alarm settings based on clinical goals and ventilator configuration [32] |
| Lack of ventilators with graphical monitoring capabilities | Although most mechanical ventilators provide waveform monitoring, its absence in some institutions hinders the detection of PVA [34]. | · Implement new ventilators |
| · Conduct financial cost analyses | ||
| · Assess economic benefits | ||
| · Train staff in equipment use [24,35,36] |
| Challenge | Explanation | Strategy |
|---|---|---|
| Underestimation of the clinical relevance and the adverse events associated with its presence | A low proportion of professionals recognize PVA in real time, indicating underestimation of both the presence and clinical impact of asynchronies [37]. | · Provide interprofessional education |
| · Train staff on the clinical impact of PVA [38] | ||
| Use of sedation to manage ventilator asynchronies | Sedation is sometimes inappropriately used to manage asynchronies [13]. | · Monitor ventilator waveforms |
| · Identify PVA | ||
| · Adjust ventilator settings according to patient condition | ||
| · Regularly reassess the patient | ||
| · Consider sedation only after confirming asynchrony and exhausting non-sedation alternatives [39,40] | ||
| Lack of communication among healthcare professionals | Lack of assertive communication among healthcare professionals can lead to misaligned goals and inconsistent treatment plans [41]. | · Implement structured interdisciplinary meetings |
| · Standardize communication protocols | ||
| · Promote coordination and alignment of therapeutic goals [42] |
PVA: patient–ventilator asynchronies; MV: mechanical ventilation.
MV: mechanical ventilation; PVA: patient–ventilator asynchronies; ICU: intensive care unit.
PVA: patient–ventilator asynchronies.